Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2002; 88(05): 871-872
DOI: 10.1055/s-0037-1613316
DOI: 10.1055/s-0037-1613316
Letters to the Editor
A Collagen Binding Assay: An Additional Method for von Willebrand Factor Activity in Therapeutic Concentrates
Authors
Further Information
Publication History
Received
10 March 2002
Accepted after resubmission
23 July 2002
Publication Date:
08 December 2017 (online)
-
References
- 1 Favaloro EJ. Collagen binding assay for von Willebrand factor (vWF:CBA): Detection of von Willebrand disease (vWD), and discrimination of vWD subtypes, depends on the collagen source. Thromb Haemost 2000; 83: 127-35.
- 2 Siekmann J, Turecek PL, Schwarz HP. The determination of von Willebrand factor activity by collagen binding assay. Haemophilia 1998; (Suppl. 03) 15-24.
- 3 Brown JE, Bosak JO. An ELBA for the binding of von Willebrand antigen to collagen. Thromb Res 1986; 43: 303-11.
- 4 Thomas KB, Choong SC, Jessat U. et al. Platelet von Willebrand factor-collagen binding activity and ristocetin cofactor activity: a comparison of methods able to differentiate von Willebrand disease types I and II (preliminary results). In: Scharrer I, Schramm W. eds 24. Hämophilie Symposium Hamburg 1993. Berlin, Heidelberg: Springer-Verlag; 1994: 234-42.
- 5 Neugebauer BM, Goy C, Budek I, Seitz R. Comparison of two von Willebrand Factor Collagen Binding Assays with Different Binding Affinities for Low, Medium and High Multimers of von Willebrand Factor. Sem Thromb Hemost 2002; 28: 139-47.
- 6 Fischer BE, Kramer G, Mitterer A. et al. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII. Thrombosis Research 1996; 84: 55-66.
- 7 Metzner HJ, Hermentin P, Cuesta-Linker T. et al. Characterisation of factor VHI/von Willebrand factor concentrates using a modified method of von Willebrand multimer analysis. Haemophilia 1998; 04 (Suppl. 03) 25-32.
- 8 Mannucci PM. Treatment of von Willebrand disease. Thromb Haemostas 2001; 86: 149-53.
- 9 Ewenstein BM. Use of ristocetin cofactor activity in the management of von Willebrand disease. Haemophilia 2001; 07 (Suppl. 01) 10-5.
- 10 Neugebauer BM, Volkers P, Seitz R. von Willebrand Factor Potency Determination by Collagen Binding Assay. A Collaborative Study for the Establishment of a European Pharmacopoeia Method. PharmEuropa 2002; 14.2: 315-27.
- 11 Assay of human von Willebrand factor. PharmEuropa 2002; 14.2: 377-8.